171 related articles for article (PubMed ID: 19678796)
21. MEN-10755. Menarini.
Jones K
Curr Opin Investig Drugs; 2003 Dec; 4(12):1473-8. PubMed ID: 14763135
[TBL] [Abstract][Full Text] [Related]
22. Epothilone D (Kosan/Roche).
Kolman A
Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
[TBL] [Abstract][Full Text] [Related]
23. Discontinued anxiolytic drugs (2009 - 2014).
Mandrioli R; Mercolini L
Expert Opin Investig Drugs; 2015 Apr; 24(4):557-73. PubMed ID: 25557457
[TBL] [Abstract][Full Text] [Related]
24. [Effect of corticotropin on endocrine gland functions in endocrine diseases].
Slavnov VN; Epshteĭn EV; Malinkovich VD; Luchitskiĭ EV; Iakovlev AA
Vrach Delo; 1979 May; (5):79-82. PubMed ID: 222075
[No Abstract] [Full Text] [Related]
25. Discontinued drugs in 2011: cardiovascular drugs.
Zhao HP; Jiang HM; Xiang BR
Expert Opin Investig Drugs; 2012 Oct; 21(10):1449-62. PubMed ID: 22827213
[TBL] [Abstract][Full Text] [Related]
26. Discontinued in 2013: diabetic drugs.
Hedrington MS; Davis SN
Expert Opin Investig Drugs; 2014 Dec; 23(12):1703-11. PubMed ID: 25251405
[TBL] [Abstract][Full Text] [Related]
27. Editorial overview: Endocrine and metabolic diseases: Waistline weapons: new therapeutic avenues for the treatment of obesity and metabolic disease.
Murphy KG
Curr Opin Pharmacol; 2015 Dec; 25():iv-vi. PubMed ID: 26559147
[No Abstract] [Full Text] [Related]
28. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.
Correia ML; Haynes WG
Expert Opin Emerg Drugs; 2005 Aug; 10(3):643-60. PubMed ID: 16083333
[TBL] [Abstract][Full Text] [Related]
29. Discontinued drugs in 2006: central and peripheral nervous system drugs.
Collins SD
Expert Opin Investig Drugs; 2007 Nov; 16(11):1743-51. PubMed ID: 17970635
[TBL] [Abstract][Full Text] [Related]
30. Discontinued psychiatric drugs in 2008.
Kirchhoff VD; Nguyen HT; Soczynska JK; Woldeyohannes H; McIntyre RS
Expert Opin Investig Drugs; 2009 Oct; 18(10):1431-43. PubMed ID: 19715445
[TBL] [Abstract][Full Text] [Related]
31. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society: executive summary.
; ; Gonzalez-Campoy JM; St Jeor ST; Castorino K; Ebrahim A; Hurley D; Jovanovic L; Mechanick JI; Petak SM; Yu YH; Harris KA; Kris-Etherton P; Kushner R; Molini-Blandford M; Nguyen QT; Plodkowski R; Sarwer DB; Thomas KT;
Endocr Pract; 2013; 19(5):875-87. PubMed ID: 24121263
[No Abstract] [Full Text] [Related]
32. Nemifitide. Innapharma.
Dingemanse J
Curr Opin Investig Drugs; 2003 Jul; 4(7):859-62. PubMed ID: 14619408
[TBL] [Abstract][Full Text] [Related]
33. [Current therapeutics 1990-1995 in the field of endocrinology-metabolism].
Scheen AJ
Rev Med Liege; 1996 Aug; 51(8):503-9. PubMed ID: 8927870
[No Abstract] [Full Text] [Related]
34. Trends in the exploration of therapeutic targets for the treatment of endocrine, metabolic and immune disorders.
Chen X; Zheng CJ; Han LY; Xie B; Chen YZ
Endocr Metab Immune Disord Drug Targets; 2007 Sep; 7(3):225-31. PubMed ID: 17897049
[TBL] [Abstract][Full Text] [Related]
35. Lapatinib ditosylate GlaxoSmithKline.
Kim TE; Murren JR
IDrugs; 2003 Sep; 6(9):886-93. PubMed ID: 12964069
[TBL] [Abstract][Full Text] [Related]
36. OSI-461 (OSI).
Galmarini CM
Curr Opin Investig Drugs; 2004 Jun; 5(6):648-56. PubMed ID: 15242254
[TBL] [Abstract][Full Text] [Related]
37. Ganstigmine. Chiesi.
Johnson A
Curr Opin Investig Drugs; 2003 Jul; 4(7):868-73. PubMed ID: 14619410
[TBL] [Abstract][Full Text] [Related]
38. Discontinued drug therapies to treat diabetes in 2015.
Hedrington MS; Davis SN
Expert Opin Investig Drugs; 2017 Feb; 26(2):219-225. PubMed ID: 27997806
[TBL] [Abstract][Full Text] [Related]
39. TLK-286.
Verschraegen CF; Smith HO; Lee FC; Cathcart C; Norenberg JP
IDrugs; 2004 Aug; 7(8):771-81. PubMed ID: 15334311
[TBL] [Abstract][Full Text] [Related]
40. The significance of new somatostatin analogs as therapeutic agents.
Zatelli MC; degli Uberti E
Curr Opin Investig Drugs; 2009 Oct; 10(10):1025-31. PubMed ID: 19777390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]